Form S-1MEF Arcus Biosciences, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Oil settles lower on peace hopes, Saudi attacks limit losses
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
Arcus Biosciences (RCUS) IPO Opens 33% Higher
March 15, 2018 10:52 AM EDTToday's IPO for Arcus Biosciences (NYSE: RCUS) opened at $20 after pricing 8,000,000 shares of common stock at a price to the public of $15.00 per share for total gross proceeds of $120,000,000.
The Company has also granted the underwriters a 30-day option to purchase from the... More



